South Carolina’s HIV/AIDS problem is an enormous one

	Tweet

South Carolina’s HIV/AIDS “problem is an enormous one,” and state lawmakers “need to review the programs that fund HIV treatment” in the state, a Columbia State editorial says. South Carolina’s HIV prevalence ranks 10th nationwide, and 74% of newly diagnosed HIV cases are among black residents, the editorial says.

In addition, HIV/AIDS advocates have said that the state budget has allocated $500,000 for the state’s AIDS Drug Assistance Program, which provides antiretroviral drugs to HIV-positive residents, whereas North Carolina allocated $12 million, according to the editorial. South Carolina’s ADAP has 144 people on the waiting list, the editorial adds.

"In our prosperous society, no one should have to wait for the medicines that control the damage that HIV does to the immune system,” the editorial says, adding, “Forcing people to wait is more than cruel; it puts off a chance to limit the disease’s damage. ... [I]f a lack of state dollars is causing people to wait for medications, that must be fixed” (Columbia State, 8/26).

RELATED STORIES:
FDA Advisory Panel Approves Home HIV Test Kit   FDA Approves New In-Home HIV Test   Home HIV test advances   Survey Reveals Support for Over-the Counter HIV Testing   F.D.A. Panel Weighs Preventive Use of H.I.V. Drug   Stem Cell Therapy Shows Promise in Fight Against HIV   Progress against HIV thwarted by patients’ unmet needs   California to test pill for HIV prevention   Mechanism of HIV spread has potential for future drug therapy   Seeking HIV treatment clues in the neem tree   HIV Prevention Pill’s Value Varies by Target   Using AIDS drugs to prevent infection: a bargain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]